Published online December 31, 2007
PEDIATRICS Vol. 121 No. 1 January 2008, pp. e15-e23 (doi:10.1542/10.1542/peds.2007-0819)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finkelstein, J. A.
Right arrow Articles by Platt, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finkelstein, J. A.
Right arrow Articles by Platt, R.
Related Collections
Right arrow Therapeutics & Toxicology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Impact of a 16-Community Trial to Promote Judicious Antibiotic Use in Massachusetts

Jonathan A. Finkelstein, MD, MPHa,b, Susan S. Huang, MD, MPHa,c, Ken Kleinman, ScDa, Sheryl L. Rifas-Shiman, MPHa, Christopher J. Stille, MD, MPHd, James Daniel, MPHe, Nancy Schiff, MPHf, Ron Steingard, MDg, Stephen B. Soumerai, ScDa, Dennis Ross-Degnan, ScDa, Donald Goldmann, MDh and Richard Platt, MDa

a Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts
b Divisions of General Pediatrics
h Infectious Diseases, Children's Hospital Boston, Boston, Massachusetts
c Channing Laboratory and Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts
d Department of Pediatrics and Meyers Primary Care Institute
g Departments of Psychiatry and Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts
e Massachusetts Department of Public Health, Boston, Massachusetts
f MassHealth, Boston, Massachusetts

OBJECTIVES. Reducing unnecessary antibiotic use, particularly among children, continues to be a public health priority. Previous intervention studies have been limited by size or design and have shown mixed results. The objective of this study was to determine the impact of a multifaceted, community-wide intervention on overall antibiotic use for young children and on use of broad-spectrum agents. In addition, we sought to compare the intervention's impact on commercially and Medicaid-insured children.

METHODS. We conducted a controlled, community-level, cluster-randomized trial in 16 nonoverlapping Massachusetts communities, studied from 1998 to 2003. During 3 years, we implemented a physician behavior-change strategy that included guideline dissemination, small-group education, frequent updates and educational materials, and prescribing feedback. Parents received educational materials by mail and in primary care practices, pharmacies, and child care settings. Using health-plan data, we measured changes in antibiotics dispensed per person-year of observation among children who were aged 3 to <72 months, resided in study communities, and were insured by a participating commercial health plan or Medicaid.

RESULTS. The data include 223135 person-years of observation. Antibiotic-use rates at baseline were 2.8, 1.7, and 1.4 antibiotics per person-year among those aged 3 to <24, 24 to <48, and 48 to <72 months, respectively. We observed a substantial downward trend in antibiotic prescribing, even in the absence of intervention. The intervention had no additional effect among children aged 3 to <24 months but was responsible for a 4.2% decrease among those aged 24 to <48 months and a 6.7% decrease among those aged 48 to <72 months. The intervention effect was greater among Medicaid-insured children and for broad-spectrum agents.

CONCLUSIONS. A sustained, multifaceted, community-level intervention was only modestly successful at decreasing overall antibiotic use beyond substantial secular trends. The more robust impact among Medicaid-insured children and for specific medication classes provides an argument for specific targeting of resources for patient and physician behavior change.


Key Words: antibiotic use • parental knowledge • randomized trial

Abbreviations: CDC—Centers for Disease Control and Prevention • REACH Mass—Reducing Antibiotics for Children in Massachusetts


Accepted Jun 7, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
AAP Grand RoundsHome page
M. Stevenson
Utility of Rapid Testing for Respiratory Viruses in the ED
AAP Grand Rounds, April 1, 2009; 21(4): 44 - 44.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
R. Ostini, D. Hegney, C. Jackson, M. Williamson, J. M Mackson, K. Gurman, W. Hall, and S. E Tett
Systematic Review of Interventions to Improve Prescribing
Ann. Pharmacother., March 1, 2009; 43(3): 502 - 513.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
D. M. Patrick MD MHSc and J. Hutchinson MD
Antibiotic use and population ecology: How you can reduce your "resistance footprint"
Can. Med. Assoc. J., February 17, 2009; 180(4): 416 - 421.
[Full Text] [PDF]


Home page
Ann Fam MedHome page
C. J. Stille, S. L. Rifas-Shiman, K. Kleinman, J. B. Kotch, and J. A. Finkelstein
Physician Responses to a Community-Level Trial Promoting Judicious Antibiotic Use
Ann. Fam. Med, May 1, 2008; 6(3): 206 - 212.
[Abstract] [Full Text] [PDF]